Search
for
Sort by
Research 571–600 of 1000+
- Advances of Microneedles for Cancer Diagnosis and Therapy
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Novel tissue mechanics-guided cellular flows drive the formation of feather follicles
- Sprayable supramolecular hydrogel with minimalism for wilderness first aid: integration of mechanical performance and biofunctionality
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- Eco-Friendly Extraction and Formulation of Black Sea Shark Liver Oil-Based Emulgel for Anti-Inflammatory and Healing Dermatocosmetic Applications
- Effect of Liquid Blood Concentrates on Cell Proliferation and Cell Cycle- and Apoptosis-Related Gene Expressions in Nonmelanoma Skin Cancer Cells: A Comparative In Vitro Study
- 1397 LSD1 is critical for epidermal development and skin barrier formation
- Regulation of self-renewal in colorectal cancer cell models
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- 5α-Reductase inhibitors in androgenetic alopecia
- Premature aging and cancer development in transgenic mice lacking functional CYLD
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- L-Cystine-Containing Hair-Growth Formulation Supports Protection, Viability, and Proliferation of Keratinocytes
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Innovative Aloe Vera Gel Formulation Containing Biogenic Silver Nanoparticles for Enhanced Scalp Health and Antimicrobial Activity
- Hair regrowth boosting via minoxidil cubosomes: Formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imaging
- Amphiregulin in Fibrotic Diseases and Cancer
- Amphiregulin in Fibrotic Diseases and Cancer
- Heavy metals in biological samples of cancer patients: a systematic literature review
- EMT Factors and Metabolic Pathways in Cancer
- Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
- A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
- PROTACs: A novel strategy for cancer drug discovery and development
- Moderate water stress in rice induces rhizosheath formation associated with abscisic acid and auxin responses